Phibro Animal Health Corp ( (PAHC) ) has released its Q2 earnings. Here is a breakdown of the information Phibro Animal Health Corp presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Phibro Animal Health Corporation is a global leader in animal health and mineral nutrition, offering solutions to enhance the health of farm and companion animals. In its latest earnings report, Phibro Animal Health Corp announced significant financial results for the second quarter of the fiscal year ending December 31, 2024, with notable revenue and profit growth. The company reported a 24% increase in net sales to $309.3 million and a net income increase to $3.2 million, largely driven by the successful integration of the Zoetis Medicated Feed Additive portfolio. Key performance metrics included a 64% rise in adjusted EBITDA to $48.2 million and a 63% increase in adjusted net income to $21.9 million. Phibro’s Animal Health segment saw remarkable growth, contributing $56.3 million to net sales, primarily due to increased demand for medicated feed additives and nutritional specialties. Looking forward, Phibro is optimistic about sustaining growth through strategic investments and innovation, projecting net sales of $1.25 billion to $1.30 billion and adjusted EBITDA of $172 million to $180 million for the fiscal year 2025.
